Titlebook: Biochemistry of Drug Resistance; Sarfraz Ahmed,Suvash Chandra Ojha,Muhammad Zaffar Book 2021 The Editor(s) (if applicable) and The Author

我沒(méi)有強(qiáng)迫

Drugs Resistance in Bacterial Diseases, in humans and animals. Major contributing factors for the development of drug resistance are the overuse of antibiotics, inaccurate implementation, extended hospitalization, and unintended prescriptions. In this chapter, the authors described the functions of the most frequently prescribed and used

搖曳

Drugs Resistance Against Viral Diseases,d by products and international travelling have resulted in the transmission of various viruses from developing countries to the America and European region. Polymerase chain reaction has been used for the confirmatory diagnosis of several viral infections due to its high specificity and sensitivity

reaching

熒光

Antifungal Drugs: Mechanism of Action and Resistance,d in increased interest in the study of antimicrobial resistance from all possible angles. The mechanisms of resistance, better methods of resistance detection, alternative methods to treat the infections of resistant organisms, and all the possible strategies to control and prevent the occurrence o

AGONY

DECRY

Drug Resistance in Skin Diseases,s in clinical practices, and a tremendous burden to the healthcare system in terms of cost and consumption of institutional resources. The emergence of drug resistance is a threat and concern in various clinical implications of skin diseases, particularly those that have secondary intervention such

kyphoplasty

chiropractor

Neurological Disorders: Biochemistry of Drug Resistance and Future Challenges, aspect of neurological disorders is the development of resistance towards drugs in clinics. Failure to achieve the required therapeutic effect with the available drugs pose severe health complications besides economic burden and there is a dire need to either combat the resistance or develop novel

Root494

Drug Resistance in Kidney Diseases,ts are finding out therapies to treat renal infections. Several drugs and therapeutics are in the market but pathogens are getting immuned to these therapies. Some pathogens are multi-drug resistant. Selection of the best immunosuppressive therapy is a complex method. Finding the balance between the

anchor